Moody’s rates LifePoint bonds Ba2

Moody's Investors Service said it assigned a Ba2 (LGD 4) rating to LifePoint Health, Inc.'s proposed senior unsecured bonds due 2024.

Proceeds will be used to redeem the company's existing $400 million 6 5/8% senior notes due 2020.

There are no changes to LifePoint's existing ratings, including the Ba2 corporate family rating and Ba2-PD probability of default rating.

The outlook is stable.

The refinancing transaction will not meaningfully impact LifePoint's credit metrics. Moody's will withdraw the ratings on the 2020 notes when those notes are redeemed.

Moody’s said the Ba2 corporate family rating reflects its expectation that the company's financial leverage will remain moderately high. The agency also expects the company to continue with its active pursuit of acquisitions.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.